Cargando…

Mixed cultures of allogeneic dendritic cells are phenotypically and functionally stable – a potential for primary cell-based “off the shelf” product generation

Vaccination against tumors using antigen-pulsed dendritic cell (DC) vaccines has greatly evolved over the last decade, with hundreds of active human clinical trials well on the way. The use of an autologous source for DC-based vaccine therapeutics remains the obvious choice in the majority of clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Švajger, Urban, Rožman, Primož J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2021
Materias:	Experimental Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568021/ https://www.ncbi.nlm.nih.gov/pubmed/34764784 http://dx.doi.org/10.5114/ceji.2021.107555

Ejemplares similares

Induction of Tolerogenic Dendritic Cells by Endogenous Biomolecules: An Update
por: Švajger, Urban, et al.
Publicado: (2018)

Synergistic Effects of Interferon-γ and Vitamin D(3) Signaling in Induction of ILT-3(high)PDL-1(high) Tolerogenic Dendritic Cells
por: Švajger, Urban, et al.
Publicado: (2019)

Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
por: Heipertz, Erica L., et al.
Publicado: (2021)

Straightforward Generation of Ultrapure Off-the-Shelf Allogeneic CAR-T Cells
por: Juillerat, Alexandre, et al.
Publicado: (2020)

Off-the-Shelf Allogeneic T Cell Therapies for Cancer: Opportunities and Challenges Using Naturally Occurring “Universal” Donor T Cells
por: Perez, Cynthia, et al.
Publicado: (2020)

HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for “Off-the-Shelf” Immunotherapy
por: Hoerster, Keven, et al.
Publicado: (2021)

Use of Cell and Genome Modification Technologies to Generate Improved “Off-the-Shelf” CAR T and CAR NK Cells
por: Morgan, Michael A., et al.
Publicado: (2020)

A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia
por: van de Loosdrecht, Arjan A., et al.
Publicado: (2018)

Allogeneic endometrial regenerative cells: An "Off the shelf solution" for critical limb ischemia?
por: Murphy, Michael P, et al.
Publicado: (2008)

Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic
por: Zhang, Xuqing, et al.
Publicado: (2021)

Combined TLR-3/TLR-8 Signaling in the Presence of α-Type-1 Cytokines Represents a Novel and Potent Dendritic Cell Type-1, Anti-Cancer Maturation Protocol
por: Fevžer, Tadej, et al.
Publicado: (2022)

The Importance of HLA Assessment in “Off-the-Shelf” Allogeneic Mesenchymal Stem Cells Based-Therapies
por: Kot, Marta, et al.
Publicado: (2019)

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
por: Li, Yan-Ruide, et al.
Publicado: (2021)

CD3 engagement as a new strategy for allogeneic “off-the-shelf” T cell therapy
por: Li, Gongbo, et al.
Publicado: (2022)

Cystatin F Affects Natural Killer Cell Cytotoxicity
por: Perišić Nanut, Milica, et al.
Publicado: (2017)

Clinical Evaluation of an Off-the-Shelf Allogeneic Adipose Matrix for Soft Tissue Reconstruction
por: Kokai, Lauren E., et al.
Publicado: (2020)

'Off-the-shelf’ allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies
por: Sinha, Debottam, et al.
Publicado: (2021)

Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML
por: Kent, Andrew, et al.
Publicado: (2023)

The Culture Dish Surface Influences the Phenotype and Cytokine Production of Human Monocyte-Derived Dendritic Cells
por: Sauter, Alexander, et al.
Publicado: (2019)

Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment
por: Oberschmidt, Olaf, et al.
Publicado: (2017)

Lynch Syndrome and MSI-H Cancers: From Mechanisms to “Off-The-Shelf” Cancer Vaccines
por: Roudko, Vladimir, et al.
Publicado: (2021)

Dendritic Cells Are Critical for the Activation and Expansion of Vδ2(+) T Cells After Allogeneic Hematopoietic Transplantation
por: Wang, Xiaoyu, et al.
Publicado: (2018)

PD-1 Blockade Promotes Emerging Checkpoint Inhibitors in Enhancing T Cell Responses to Allogeneic Dendritic Cells
por: Stecher, Carmen, et al.
Publicado: (2017)

Overview of Cellular Immunotherapies within Transfusion Medicine for the Treatment of Malignant Diseases
por: Tešić, Nataša, et al.
Publicado: (2021)

Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High-Risk Patients with COVID-19
por: Vasileiou, Spyridoula, et al.
Publicado: (2021)

Dendritic Cell Therapy in an Allogeneic-Hematopoietic Cell Transplantation Setting: An Effective Strategy toward Better Disease Control?
por: Plantinga, Maud, et al.
Publicado: (2014)

Novel Targeting to XCR1(+) Dendritic Cells Using Allogeneic T Cells for Polytopical Antibody Responses in the Lymph Nodes
por: Kitazawa, Yusuke, et al.
Publicado: (2019)

‘Off the shelf’ immunotherapies: Generation and application of pluripotent stem cell‐derived immune cells
por: Wang, Chenxin, et al.
Publicado: (2023)

Post-radiation xerostomia therapy with allogeneic mesenchymal stromal stem cells in patients with head and neck cancer: study protocol for phase I clinical trial
por: Strojan, Primoz, et al.
Publicado: (2023)

Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
por: Zhang, Congcong, et al.
Publicado: (2017)

Proinflammatory allogeneic dendritic cells enhance the therapeutic efficacy of systemic anti-4-1BB treatment
por: Ali, Arwa, et al.
Publicado: (2023)

iStable: off-the-shelf predictor integration for predicting protein stability changes
por: Chen, Chi-Wei, et al.
Publicado: (2013)

Using Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High Risk Patients with COVID-19
por: Vasileiou, Spyridoula, et al.
Publicado: (2020)

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting
por: Pfeiffer, Thomas, et al.
Publicado: (2023)

Carcinogens off the Shelf?
por: Stewart, Bernard W
Publicado: (2018)

C-type lectin DC-SIGN: An adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity
por: Švajger, Urban, et al.
Publicado: (2010)

A Comparison of Ex Vivo Expanded Human Regulatory T Cells Using Allogeneic Stimulated B Cells or Monocyte-Derived Dendritic Cells
por: Lee, Linda M., et al.
Publicado: (2021)

Dendritic Cells in the Cross Hair for the Generation of Tailored Vaccines
por: Gornati, Laura, et al.
Publicado: (2018)

Human Apoptotic Cells, Generated by Extracorporeal Photopheresis, Modulate Allogeneic Immune Response
por: Pilon, Caroline, et al.
Publicado: (2019)

Cord blood-derived CD19-specific chimeric antigen receptor T cells: an off-the-shelf promising therapeutic option for treatment of diffuse large B-cell lymphoma
por: Yu, Tiantian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_audp91qujcfr2r5fsocutacd43